FA
FIRST ADVANTAGE CORP (FA)·Q3 2024 Earnings Summary
Executive Summary
- Q3 2024 revenue was $199.1M (-0.6% y/y) with Adjusted EBITDA of $64.0M and 32.2% margin; GAAP net loss of $(8.9)M reflected $13.2M of Sterling acquisition-related expenses, while adjusted diluted EPS was $0.26 .
- Stand-alone FY2024 guidance was maintained (Revenue $750–$800M; Adj. EBITDA $228–$248M; Adj. diluted EPS $0.88–$0.98), and new FY2024 combined-company guidance including Sterling (Nov–Dec) was introduced (Revenue $858–$918M; Adj. EBITDA $250–$274M; Adj. diluted EPS $0.83–$0.95) .
- Acquisition of Sterling closed on Oct 31 (enterprise value ~$2.2B); management has already actioned >$10M of run-rate cost synergies with line of sight to $50–$70M within two years; deleveraging to ~3x within ~24 months remains the target .
- Q3 cash from operations was $43.5M (would have been $45.3M excluding $1.8M of Sterling cash costs), and the company highlighted sequential improvement in revenue and margins with Q4 stand-alone expected to grow again q/q; base hiring volumes remained softer than expected but stabilizing .
What Went Well and What Went Wrong
What Went Well
- Early synergy capture: “We have already actioned over $10 million in run rate cost synergies, with line of sight to actioning $50–$70 million within 2 years post-close.” (CEO) .
- Margin resilience and sequential improvement: Adjusted EBITDA margin was 32.2% in Q3 (up from 30.2% in Q2 and 27.5% in Q1), with management reiterating sequential q/q growth into Q4 .
- Sales engine consistency and bookings: 16 enterprise bookings (≥$500K ACV) in Q3; 53 in the last 12 months; upsell/cross-sell/new logo rates performing in line with the historical growth algorithm (CEO) .
What Went Wrong
- GAAP loss on higher non-recurring costs: Net loss $(8.9)M with net loss margin (4.4)%, driven by $13.2M of Sterling transaction costs and higher y/y interest expense ($17.2M vs. $7.6M) .
- Base demand modest: Management cited base revenue coming in lower than anticipated; macro hiring remains “stabilizing/normalizing” vs. robust, and stand-alone FY2024 is now seen above the low end but below the midpoint of prior guidance .
- 2025 accretion cadence: EPS accretion expected to be more neutral in 2025 due to timing of synergy realization versus immediate interest expense and dilution; accretion ramps as synergies are achieved (Mgmt in Q&A) .
Financial Results
Consolidated P&L and EPS (oldest → newest)
Geography/Segment Revenue (oldest → newest)
Selected KPIs (oldest → newest)
Notes: Q3 GAAP net loss includes $13.2M Sterling-related transaction costs . Q3 CFO would have been $45.3M adjusting for $1.8M Sterling acquisition cash costs .
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We are thrilled to have closed our $2.2 billion acquisition of Sterling on October 31… [with] combined revenues of approximately $1.5 billion and adjusted EBITDA of approximately $407 million… including our targeted run rate synergies of $50 million to $70 million” (CEO) .
- “We have already made significant progress towards this target with over $10 million of run rate cost synergies actioned on day 1… and have identified additional synergy opportunities [to] approximately double the actioned synergies within the next 100 days” (CEO) .
- “In Q3 2024, First Advantage stand-alone generated strong adjusted operating cash flows of $45.3 million, a robust 32% increase versus prior year… [and] sequentially… increased 11% from Q2” (CFO) .
- “We expect total [combined] revenues in the range of $858 million to $918 million and adjusted EBITDA of $250 million to $274 million… adjusted diluted EPS… $0.83 to $0.95 for 2024” (CFO) .
- On integration approach: “We’re not going to force migrate customers onto a given platform… our synergy numbers don’t require that… customers should feel an upgrade of service and products” (CEO) .
Q&A Highlights
- Base volumes and macro: Management characterized the stand-alone guidance skew as “bouncing around the bottom,” with stabilization but modest hiring/backfill dynamics persisting (CEO) .
- Sterling mix/retention: Sterling retention ~96–97% with some mix headwind (upsell skew to drug/healthcare lowered margins; attrition occurred more in higher-margin traditional screening) (CEO) .
- 2025 accretion cadence: Not a change to synergy outlook; neutral reported EPS accretion in 2025 due to timing of synergy capture versus immediate interest/dilution, with accretion achieved as synergies ramp (Mgmt) .
- Upsell/cross-sell momentum: Customers prioritizing safety/compliance and brand protection over cost cutting; package density and digital identity solutions expected to support continued upsell/cross-sell strength (Mgmt) .
- Integration discipline: No forced platform migrations; first quick-win feature for Sterling customers likely Click.Chat.Call service chat within ~4–6 months; daily GTM standups to minimize distraction (CEO) .
Estimates Context
- Wall Street consensus (S&P Global) for Q3 2024 EPS/Revenue/EBITDA was unavailable at this time due to data access limits; therefore, we cannot quantify beat/miss versus consensus for Q3 2024. Management did not provide explicit vs-consensus commentary in the press release/8-K or call .
- We will update beat/miss analysis when S&P Global consensus becomes available.
Key Takeaways for Investors
- Margin durability: Despite flat y/y revenue, FA expanded adjusted EBITDA margins sequentially to 32.2% and delivered $64.0M Adjusted EBITDA; GAAP loss was driven by non-recurring deal costs and higher interest expense .
- Integration execution as catalyst: >$10M synergies actioned at close, with a clear line of sight to $50–$70M within two years, no forced platform migrations, and early product upgrade opportunities for Sterling customers (e.g., chat) .
- Deleveraging path: Pro forma net leverage ~4.4x with a stated path to ~3x within ~24 months, aided by swaps fixing ~40% of post-acquisition debt and anticipated rate cuts (Mgmt) .
- Guidance steady; combined guide introduced: Stand-alone FY2024 maintained; combined FY2024 guide sets a new baseline (Revenue $858–$918M; Adj. EBITDA $250–$274M; Adj. EPS $0.83–$0.95) .
- Demand backdrop: Macro hiring remains stable/normalized at modest levels; base came in lower than anticipated, but q/q growth into Q4 is expected on a stand-alone basis (Mgmt) .
- 2025 framing: Expect a more “neutral” reported EPS accretion in 2025 due to the timing of synergy realization versus interest/dilution; accretion should materialize as synergies scale (Mgmt) .
- Watch-list catalysts: Quarterly synergy cadence updates, Q4 sequential performance, integration milestones (feature rollouts to Sterling base), deleveraging progress, and macro hiring traction—these are likely to drive stock narrative (Mgmt commentary) .
Appendix: Additional Relevant Disclosures
- Q3 highlights from press release: “Revenues of $199.1 million… Adjusted EBITDA $64.0 million (32.2% margin)… GAAP Diluted Net Loss Per Share of $(0.06), includes $0.07 per share of Sterling costs; Adjusted Diluted EPS $0.26” .
- Sterling close: “Valued at $2.2 billion… expected $50–$70 million run-rate synergies” .
- Stand-alone vs Combined guidance tables in 8-K/press release (Nov 12) .